Merck Life Execs On APAC Firms' mRNA Tech Readiness, Start-Ups And AI

VCs Lack Understanding Of Biotechs

Merck Life Science’s top executives in India tell Scrip how they are helping biologics companies in APAC on their mRNA therapy journey. In the wide-ranging discussion, use of AI, the startup environment for biotechs and the changing face of manufacturing in India also came up.

Aditya Sharma & Tathagata Ray
Merck Life Science Leaders Aditya Sharma And Tathagata Ray Share Views With Scrip • Source: Merck

Top executives of Merck Life Science, Merck KGaA’s arm offering research and manufacturing products and solutions for chemical and biological drugs, in India say “almost everyone” in the biologics space is looking to build mRNA platforms, with their customers being at varied stages in this journey.

Japan, China, South Korea and India are some of the large countries within APAC where “we see a lot of...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

More from Scrip